CELU
Celularity Inc.
$0.99
+$0.08(+8.29%)
37
Overall
40
Value
27
Tech
44
Quality
Market Cap
$25.96M
Volume
294.93K
52W Range
$0.87 - $4.35
Target Price
$6.00
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $14.3M | $21.3M | $18.0M | $22.8M | $54.2M | $26.6M | ||
| Total Revenue | $14.3M | $21.3M | $18.0M | $22.8M | $54.2M | $26.6M | ||
| COST OF GOODS SOLD | ||||||||
| Cost of Revenue | $4.9M | $9.7M | $19.7M | $16.0M | $15.0M | $20.1M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $9.3M | $11.7M | $-1.7M | $6.8M | $39.2M | $6.5M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $145.7M | $206.7M | $146.6M | $83.2M | $77.8M | $67.8M | ||
| Research & Development | $52.7M | $92.0M | $78.4M | $30.5M | $17.4M | $15.0M | ||
| Research Expense | $52.7M | $88.4M | $78.4M | $30.5M | $17.4M | $15.0M | ||
| Selling, General & Administrative | $33.6M | $71.3M | $66.0M | $50.6M | $58.6M | $51.3M | ||
| Selling & Marketing Expenses | $2.3M | $252.0K | $163.0K | $44.0K | -- | -- | ||
| General & Administrative Expenses | $31.3M | $71.3M | $66.0M | $50.6M | $58.6M | $51.3M | ||
| Promotion & Advertising | $2.3M | -- | -- | -- | -- | -- | ||
| Salaries & Wages | $55.6M | $41.1M | -- | -- | -- | -- | ||
| Depreciation & Amortization | $3.4M | $2.2M | $2.2M | $2.2M | $1.8M | $1.5M | ||
| Depreciation & Amortization | $3.4M | $2.2M | $2.2M | $2.2M | $1.8M | $1.5M | ||
| Amortization | $3.4M | $2.2M | $2.2M | $2.2M | $1.8M | $1.5M | ||
| Other Operating Expenses | $391.0K | $-242.0K | $4.6M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||
| Operating income | $-151.9M | $-109.1M | $-25.6M | $-192.3M | $-38.4M | $-61.3M | ||
| EBITDA | $-202.4M | $-88.1M | $23.6M | $-183.9M | $-50.0M | $-84.4M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $2.4M | $3.2M | -- | -- | $6.3M | -- | ||
| Intinc | $1.8M | -- | -- | -- | $331.0K | -- | ||
| Net Non-Operating Interest Income/Expense | $1.8M | -- | $-365.0K | -- | $-5.9M | -- | ||
| Gain on Sale of Securities | $2.2K | -- | -- | -- | -- | $65.0K | ||
| Other Income/Expense | $190.4M | $-3.0M | $-42.5M | $-8.0K | $9.3M | $19.0M | ||
| Other Special Charges | $-56.6M | $9.0M | $42.5M | $3.5M | $-9.4M | $-16.2M | ||
| SPECIAL ITEMS | ||||||||
| Special Income Charges | $-2.2M | -- | $-3.6M | $-112.3M | -- | -- | ||
| Impairment of Capital Assets | -- | -- | $3.6M | $112.3M | -- | -- | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-210.6M | $-96.9M | $14.2M | $-193.3M | $-57.9M | $-91.7M | ||
| Pre-Tax Income | $-212.9M | $-100.1M | $14.2M | $-196.3M | $-57.9M | $-91.7M | ||
| INCOME TAX | ||||||||
| Tax Provision | $-4.7M | $20.0K | $13.0K | $10.0K | -- | $3.0K | ||
| NET INCOME | ||||||||
| Net Income | $-208.2M | $-100.1M | $14.2M | $-196.3M | $-57.9M | $-91.7M | ||
| Net Income (Continuing Operations) | $-208.2M | $-100.1M | $14.2M | $-196.3M | $-57.9M | $-91.7M | ||
| Net Income (Discontinued Operations) | $-208.2M | $-100.1M | $14.2M | $-196.3M | $-57.9M | $-91.7M | ||
| Net Income (Common Stockholders) | $-208.2M | $-100.1M | $-109.4M | $-196.3M | $-57.9M | $-91.8M | ||
| Normalized Income | -- | $-75.5M | -- | -- | -- | $-87.9M | ||
| TOTALS | ||||||||
| Total Expenses | $229.7M | $366.4M | $166.2M | $99.3M | $92.8M | $87.9M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $8.7M | $67.1M | $14.0M | $17.8M | $21.9M | $25.6M | ||
| Average Shares Outstanding (Diluted) | $8.7M | -- | $15.0M | $17.8M | $21.9M | $25.6M | ||
| Shares Outstanding | $35.9M | $137.7M | $16.5M | $22.0M | $23.9M | $28.9M | ||
| Basic EPS | -- | $-1.49 | $1 | $-11.02 | $-2.64 | $-3.59 | ||
| Basic EPS (Continuing Operations) | -- | $-1.49 | $1 | $-11.02 | $-2.64 | $-3.59 | ||
| Diluted EPS | $-0.45 | $-1.49 | $0.90 | $-11.02 | $-2.64 | $-3.59 | ||
| Diluted EPS (Continuing Operations) | $-0.45 | -- | $0.90 | $-11.02 | $-2.64 | $-3.59 | ||
| OTHER METRICS | ||||||||
| Accretion On Preferred Stock | $-1.3M | -- | -- | -- | -- | -- | ||
| Allowances For Construction | -- | $2.5M | -- | -- | -- | -- | ||
| Depletion | -- | $3.6M | -- | -- | -- | -- | ||
| Development Expense | -- | $3.6M | -- | -- | -- | -- | ||
| Fees | $5.0M | -- | -- | -- | -- | -- | ||
| Gain On Sale Of Business | $-4.4M | -- | -- | -- | -- | -- | ||
| Marketing Expense | $764.0K | $252.0K | $163.0K | -- | -- | -- | ||
| Non Recurring Operation Expense | $2.2M | -- | -- | -- | -- | -- | ||
| Other Gand A | $31.3M | $71.3M | $66.0M | $50.6M | $58.6M | $51.3M | ||
| Other Impairment Of Capital Assets | $129.4M | -- | -- | $107.8M | -- | $2.9M | ||
| Other Write Off | -- | $3.5M | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $-1.3M | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $1.6M | $668.0K | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CELU | $0.99 | +8.3% | 294.93K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |